Carta Healthcare has secured $18.25 million in Series B1 funding to bolster the development and deployment of its AI-powered clinical data abstraction and analytics platform. This funding round reinforces the company’s growing reputation in healthcare technology, with a particular focus on transforming how hospitals manage, process, and extract value from clinical data. Carta’s flagship platform, Atlas, uses AI to automate the traditionally manual, time-intensive task of data abstraction, significantly reducing operational inefficiencies and enabling faster, more accurate data-driven decisions in clinical settings.

The infusion of capital comes at a time when healthcare systems are increasingly seeking scalable digital solutions to meet quality reporting standards and support value-based care initiatives. Carta’s ability to streamline and standardize data abstraction through automation positions it strategically to serve a critical market need. By reducing reliance on manual workflows and providing structured data for analytics and compliance, Carta addresses key pain points faced by healthcare administrators and clinicians alike. This not only improves hospital operations but also enhances patient care by allowing healthcare professionals to refocus on clinical decision-making.

With this latest funding, Carta Healthcare is well-positioned to expand its footprint across U.S. health systems and deepen its technological capabilities. The successful Series B1 round signals strong investor confidence and growing market demand for intelligent data infrastructure in healthcare. As the industry continues to shift toward AI-driven solutions, Carta’s innovative approach to clinical data management is likely to play a central role in supporting more efficient, accurate, and patient-centered care delivery.